The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksUpdated•Originally published 5 April 2026•Updated 5 April 2026•

1 min read

Mixed Institutional Sentiment for Texas Instruments Amid Stake Reductions and New Buys

Key Facts

1SteelPeak Wealth LLC reduced its stake in Texas Instruments by 92.7% during the fourth quarter.

2Major institutions including Amundi, Invesco, and VanEck made substantial purchases of the company's shares.

about 2 months ago

Version History

1 additional source confirmed this story

Version 1about 2 months ago

What changed: Updated to include new filing data from Stratos Wealth Partners showing increased stakes in Texas Instruments and Netflix, alongside a reduction in Medtronic holdings.

Recent regulatory filings continue to highlight mixed institutional sentiment for Texas Instruments (TXN), with Stratos Wealth Partners LTD. increasing its position by 6.5% to 62,042 shares. This move aligns with broader institutional reshuffling, as Stratos also aggressively expanded its Netflix holdings by over 1,000% while trimming its stake in Medtronic by 9.1%. These updates follow a significant 92.7% stake reduction by SteelPeak Wealth LLC, contrasted by increased holdings from Amundi, Invesco, and VanEck. Despite a slight miss in fourth-quarter earnings and revenue, Texas Instruments remains committed to its $1.42 per share quarterly dividend. The diverse trading patterns reflect a period of strategic portfolio rebalancing as asset managers weigh recent insider selling against long-term yield.